AGL 38.02 Increased By ▲ 0.08 (0.21%)
AIRLINK 197.36 Increased By ▲ 3.45 (1.78%)
BOP 9.54 Increased By ▲ 0.22 (2.36%)
CNERGY 5.91 Increased By ▲ 0.07 (1.2%)
DCL 8.82 Increased By ▲ 0.14 (1.61%)
DFML 35.74 Decreased By ▼ -0.72 (-1.97%)
DGKC 96.86 Increased By ▲ 4.32 (4.67%)
FCCL 35.25 Increased By ▲ 1.28 (3.77%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 13.17 Increased By ▲ 0.42 (3.29%)
HUBC 127.55 Increased By ▲ 6.94 (5.75%)
HUMNL 13.50 Decreased By ▼ -0.10 (-0.74%)
KEL 5.32 Increased By ▲ 0.10 (1.92%)
KOSM 7.00 Increased By ▲ 0.48 (7.36%)
MLCF 44.70 Increased By ▲ 2.59 (6.15%)
NBP 61.42 Increased By ▲ 1.61 (2.69%)
OGDC 214.67 Increased By ▲ 3.50 (1.66%)
PAEL 38.79 Increased By ▲ 1.21 (3.22%)
PIBTL 8.25 Increased By ▲ 0.18 (2.23%)
PPL 193.08 Increased By ▲ 2.76 (1.45%)
PRL 38.66 Increased By ▲ 0.49 (1.28%)
PTC 25.80 Increased By ▲ 2.35 (10.02%)
SEARL 103.60 Increased By ▲ 5.66 (5.78%)
TELE 8.30 Increased By ▲ 0.08 (0.97%)
TOMCL 35.00 Decreased By ▼ -0.03 (-0.09%)
TPLP 13.30 Decreased By ▼ -0.25 (-1.85%)
TREET 22.16 Decreased By ▼ -0.57 (-2.51%)
TRG 55.59 Increased By ▲ 2.72 (5.14%)
UNITY 32.97 Increased By ▲ 0.01 (0.03%)
WTL 1.60 Increased By ▲ 0.08 (5.26%)
BR100 11,727 Increased By 342.7 (3.01%)
BR30 36,377 Increased By 1165.1 (3.31%)
KSE100 109,513 Increased By 3238.2 (3.05%)
KSE30 34,513 Increased By 1160.1 (3.48%)

LONDON/NEW YORK: British bank Barclays faces an estimated 450 million pound ($592 million) loss and regulatory scrutiny for exceeding a US limit on sales of structured products, some of which have surged in popularity since Russia’s invasion of Ukraine.

Barclays also said on Monday that it will have to delay a planned 1 billion pound share buyback as of the loss, which it will have to incur as a result of buying back the securities in question at their original purchase price.

Shares in Barclays closed down 4% after the bank said it had oversold billions of pounds worth of the securities over a period of about a year, overshooting a $20.8 billion limit agreed with United States regulators by $15.2 billion.

The major regulatory blunder is an early embarrassment for C.S. Venkatakrishnan, the newly-appointed chief executive of Barclays, whose previous roles included heading up the bank’s global markets and risk operations.

Analysts at Shore Capital said in a note that Barclays appeared to be “tripping over its shoelaces”.

The wider investment bank had previously proved a stellar performer for Barclays over recent years, helping it to post a record annual profit for 2021.

While the current share buyback has only been delayed, the error could reduce future capital distributions to shareholders by the bank, the Shore Capital analysts said.

In a further blow after the London market close, a Goldman Sachs note seen by Reuters showed that the US investment bank had been instructed by one of Barclays’ top investors to sell a significant chunk of stock in the bank.

The target price range for the sale of 575 million Barclays’ shares was 6.1-8.1% lower than the closing price, a factor which is likely to put further pressure on the stock price when it opens on Tuesday.

VOLATILITY BETS The products involved include two exchange-traded notes (ETNs) linked to crude oil and market volatility , a source familiar with the matter said. Barclays suspended sales and issuance of both this month.

Before sales were suspended, the so-called VXX product had surged in popularity as investors placed bets on volatility as the Ukraine crisis roiled global markets, with the number of shares changing hands daily doubling to 71 million in a month.

Barclays said at the time that capacity issues were to blame and the actions were not linked to the crisis in Ukraine.

The bank said on Monday its best estimate was that the loss on the affected securities would amount to 450 million pounds, cutting its core capital ratio to the middle of its 13-14% target range. The loss estimate did not include tax.

Barclays said it would delay its share buyback until the second quarter of the year as a result.

Comments

Comments are closed.